Dr. Reddy's Downgraded By Systematix After Semaglutide Setback; Target Price Cut
The brokerage's cautious stance comes after Dr Reddy's disclosed that it had temporarily suspended commercial supplies of Semaglutide injections following the identification of an out-of-specification...
\